Etiological, pathogenetic and clinical aspects of skin diseases in patients with Parkinson disease.
pdf

Keywords

Parkinson’s disease, skin diseases, early diagnosis.

How to Cite

Hertsev , V., Stoyanov , O., Muratova , T., & Vastyanov , R. (2018). Etiological, pathogenetic and clinical aspects of skin diseases in patients with Parkinson disease. The Journal of Neuroscience, 6(1), 81-87. Retrieved from https://neuroscience.com.ua/index.php/journal/article/view/64

Abstract

In the review article describe clinical manifestations of the most common skin lesions in Parkinson’s disease and also describe the original algorithm for their prevention, timely diagnosis and treatment. Also examples of using of skin tests for early diagnosis of Parkinson’s disease describe as well as the plans of further researches of this problem.

pdf

References

1. Staging of brain pathology related to sporadic Parkinson’s disease / H. Braak, K. Del Tredici, V. Rub [et al.] // Neurobiol. Aging. — 2003. — Vol. 24. — P. 194-211.
2. Brooks D.J. The early diagnosis of Parkinson’s disease / D.J. Brooks // Ann. Neurol. — 1998. — Vol. 44, Suppl. 1. — P. 10-18.
3. Hawkes C.H. Parkinsons disease: a dual-hit hypothesis / C.H. Hawkes, K. Del Tredici, H. Braak // Neuropathol. Appl. Neurobiol. — 2007. — Vol. 33. — P. 599-614.
4. Gupta A.K., Madzia S.E., Batra R. Etiology and management of seborrheic dermatitis // Dermatology. — 2004. — Vol. 208 (2). — Р. 89-93.
5. Dessinioti C., Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies // Clin. Dermatol. — 2013. — Vol. 31 (4). —
Р. 343-351.
6. Naldi L., Rebora A. Clinical practice. Seborrheic dermatitis // N. Engl. J. Med. — 2009. — Vol. 360 (4). — Р. 387-396.
7. Gregory R., Miller S. Parkinson’s disease and the skin // Pract. Neurol. — 2015. — Vol. 15 (4). — Р. 246-249.
8. Arsic Arsenijevic V.S., Milobratovic D., Barac A.M., Vekic B., Marinkovic J., Kostic V.S. A laboratory-based study on patients with Parkinson’s disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production // BMC Dermatol. — 2014. — Vol. 14. — Р. 5.
9. Tanner C., Albers K., Goldman S. et al. Seborrheic Dermatitis and Risk of Future Parkinson’s Disease // Neurology. — 2012. — Vol. 78 (1). — Р. 2012.
10. Aono J., Mamiya K. Patients with Parkinson’s disease are often accompanied with athlete’s foot // Mycoses. — 2013 Jan. — Vol. 56 (1). — Р. 89.
11. Герцев В.Н., Добровольский В.В., Судья Д., Лебедь Е.П., Перькова А.В. Materialy ХI Mezinarodni vedekoprakticka conference «AKTUÀLNÍ VYMOŽENOSTI
VĔDY». — Dil 6. — Lekarstvi — Praha: Publishing House, 2015. — P. 9-10.
12. Parkinson’s syndrome in young women with myeloperoxidase deficiency of phagocytes / V.Ye. Kazmirchuk, D.V. Maltsev, T.N. Slobodin, Yu.I. Golovchenko // Int. Neurol. J. — 2011. — № 1. — P. 15-24.
13. Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans /
Y. Aratani, F. Kura, H. Watanabe [et al.] // J. Infect. Dis. — 2002. — Vol. 185, № 12. — P. 1833-1837.
14. Fungal-derived semiochemical 1-octen‑3-ol disrupts dopamine packaging and causes neurodegeneration / A.A. Inamdar, M.M. Hossain, A.I. Bernstein [et al.] //
PNAS. — 2013. — Vol. 110, N48. — P. 19561-19566.
15. Tan J., Berg M. Rosacea: current state of epidemiology // J. Am. Acad. Dermatol. — 2013. — Vol. 69 (6 Suppl. 1). — Р. S27-S35.